RBC Raises Price Target on Agios Pharmaceuticals to $57 From $55, Keeps Outperform Rating
RBC Raises Price Target on Agios Pharmaceuticals to $57 From $55, Keeps Outperform Rating
RBC將Agios Pharmaceuticals的目標價從55美元上調至57美元，並維持其「跑贏大盤」評級。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間